HRS-1738 imaging test for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests an investigational imaging agent, HRS-1738, to see if it can help detect prostate cancer during a PET/CT scan. It may help doctors better see and diagnose prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a man aged 18 or older.
- You must have prostate cancer confirmed by a biopsy.
- You must be in generally good health (able to care for yourself and up and about).
- You must have had no surgery for at least 8 weeks before joining.
- You must agree to use effective birth control during the study and for one week after the last dose.
- You must not have other serious illnesses, active infections, or conditions that would make a PET/CT scan unsafe or hard to interpret.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new radioactive tracer that may help doctors see and treat prostate cancer that has spread. The tracer attaches to cancer cells so they show up on scans, and may also help guide treatment.
This study tests a new imaging agent (68Ga-NYM032) used with PET/CT scans to help doctors better detect prostate cancer before surgery. If you have biopsy-confirmed prostate cancer and are planning to have your prostate removed, this trial may help evaluate whether this new imaging method improves cancer detection.
This trial tests a new imaging drug that may help your doctor see the exact location of prostate cancer using a PET scan. The imaging is done before surgery to remove the prostate or, if you have recurrence, to find where the cancer has returned.
This study tests a new imaging method (PET scan) that uses a special tracer to find prostate cancer cells, whether it's the first diagnosis or a recurrence after treatment. The goal is to see how well this imaging works for locating cancer in the body.
This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.
This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.
Hear when a new PET Imaging in Patients With Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.